+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleotides Market by Product Type, Application, End User, Synthesis Technology, Purity Grade, Market Channel - Global Forecast to 2030- Product Image
Nucleotides Market by Product Type, Application, End User, Synthesis Technology, Purity Grade, Market Channel - Global Forecast to 2030- Product Image
Sale

Nucleotides Market by Product Type, Application, End User, Synthesis Technology, Purity Grade, Market Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666194
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Nucleotides Market is navigating a period of dynamic transformation, fueled by scientific advances, regulatory evolution, and diversification into new applications. Senior leaders in pharmaceuticals, biotechnology, and adjacent sectors are recognizing the strategic significance of high-quality nucleotide solutions in driving competitive advantage and innovation across multiple domains.

Market Snapshot: Nucleotides Market Size & Growth Outlook

The Nucleotides Market grew from USD 652.30 million in 2024 to USD 708.29 million in 2025. It is expected to continue growing at a CAGR of 8.42%, reaching USD 1.06 billion by 2030. This robust momentum reflects heightened investments in genetic therapies, advanced diagnostics, and industrial applications, as well as increased focus on reliable supply chains and quality standards across all key regions.

Scope & Segmentation

This research delivers an in-depth analysis of the global Nucleotides Market, spanning all vital segments, regions, and emerging technologies:

  • Product Types: Mononucleotides, Oligonucleotides, Polynucleotides
  • Application Areas: Agriculture, Animal Health, Cosmetics, Diagnostics, Food and Beverage, Pharmaceuticals (Genetic Disorders, Infectious Diseases, Oncology)
  • End Users: Academic and Research Institutes, Contract Research Organizations, Pharmaceutical and Biotech Companies
  • Synthesis Technologies: Chemical Synthesis, Enzymatic Synthesis
  • Purity Grades: Clinical Grade, Research Grade
  • Market Channels: Direct Sales, Distributors
  • Geographies: Americas (United States – including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Evonik Industries AG, Ajinomoto Co., Inc., DuPont de Nemours, Inc., Kyowa Hakko Bio Co., Ltd., Nitto Denko Corporation, Yamasa Corporation, Koninklijke DSM N.V., Fujifilm Holdings Corporation, Amicogen Co., Ltd., Global Bio-Chem Technology Group Co., Ltd.

Key Takeaways for Leaders

  • Innovation across synthesis technologies, especially the adoption of enzymatic approaches, is promoting cost efficiency, environmental stewardship, and access to higher-purity nucleotides.
  • Market opportunities are emerging outside traditional pharma, including in agriculture for sustainable crop and livestock solutions, and in cosmetics via reparative biomolecule applications.
  • Strategic partnerships between manufacturers, distributors, and research institutions drive rapid product development and broader market reach, especially for advanced genetic therapies.
  • Localized manufacturing and nearshoring strategies are becoming critical, particularly in light of recent and upcoming trade policy changes affecting supply continuity and cost structures.
  • Quality assurance and traceability, supported by digital supply chain innovations, are essential in minimizing risks tied to contamination or counterfeiting, especially for clinical use.

Nucleotides Market Tariff Impact

The introduction of revised U.S. tariffs in 2025 adds a complex dimension to global nucleotide sourcing. Increased import duties on essential raw materials and finished products are pushing organizations to reconfigure their procurement and supply networks, with a marked trend toward nearshoring and strategic collaboration with North American partners. This shift is fostering deeper cooperation between producers and distributors, as well as refined inventory strategies to maintain continuous access for critical research and clinical pipelines.

Methodology & Data Sources

This report employs a multidisciplinary methodology, incorporating primary interviews with senior executives, frontline scientists, and supply chain professionals. Secondary research includes analysis of white papers, regulatory filings, patents, and published market reports. Rigorous data triangulation and cross-verification underpin the reliability of conclusions presented here.

Why This Report Matters

  • It delivers an actionable benchmarking tool for senior decision-makers navigating the complexities of product selection, market entry, and expansion within the global Nucleotides Market.
  • The report outlines how evolving technology, regulation, and trade policies interplay, enabling tailored strategies for sourcing, innovation, and risk mitigation across multiple regions and channels.
  • In-depth company profiles and segmentation provide leaders with a clear view of competitors and potential partners shaping the future of nucleotide commercialization.

Conclusion

The Nucleotides Market is entering a new era defined by accelerating innovation, supply chain adaptation, and the emergence of broad, high-value applications. Leaders who proactively engage with these dynamics will be better positioned to secure sustained growth and navigate future disruptions in this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nucleotides Market, by Product Type
8.1. Introduction
8.2. Mononucleotides
8.3. Oligonucleotides
8.4. Polynucleotides
9. Nucleotides Market, by Application
9.1. Introduction
9.2. Agriculture
9.3. Animal Health
9.4. Cosmetics
9.5. Diagnostics
9.6. Food and Beverage
9.7. Pharmaceuticals
9.7.1. Genetic Disorders
9.7.2. Infectious Diseases
9.7.3. Oncology
10. Nucleotides Market, by End User
10.1. Introduction
10.2. Academic and Research Institutes
10.3. Contract Research Organizations
10.4. Pharmaceutical and Biotech Companies
11. Nucleotides Market, by Synthesis Technology
11.1. Introduction
11.2. Chemical Synthesis
11.3. Enzymatic Synthesis
12. Nucleotides Market, by Purity Grade
12.1. Introduction
12.2. Clinical Grade
12.3. Research Grade
13. Nucleotides Market, by Market Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
14. Americas Nucleotides Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Nucleotides Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Nucleotides Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Evonik Industries AG
17.3.2. Ajinomoto Co., Inc.
17.3.3. DuPont de Nemours, Inc.
17.3.4. Kyowa Hakko Bio Co., Ltd.
17.3.5. Nitto Denko Corporation
17.3.6. Yamasa Corporation
17.3.7. Koninklijke DSM N.V.
17.3.8. Fujifilm Holdings Corporation
17.3.9. Amicogen Co., Ltd.
17.3.10. Global Bio-Chem Technology Group Co., Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NUCLEOTIDES MARKET MULTI-CURRENCY
FIGURE 2. NUCLEOTIDES MARKET MULTI-LANGUAGE
FIGURE 3. NUCLEOTIDES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NUCLEOTIDES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEOTIDES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEOTIDES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NUCLEOTIDES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NUCLEOTIDES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NUCLEOTIDES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEOTIDES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NUCLEOTIDES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEOTIDES MARKET SIZE, BY MONONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NUCLEOTIDES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEOTIDES MARKET SIZE, BY POLYNUCLEOTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEOTIDES MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NUCLEOTIDES MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEOTIDES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NUCLEOTIDES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEOTIDES MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEOTIDES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NUCLEOTIDES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEOTIDES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NUCLEOTIDES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEOTIDES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NUCLEOTIDES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEOTIDES MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEOTIDES MARKET SIZE, BY CLINICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NUCLEOTIDES MARKET SIZE, BY RESEARCH GRADE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NUCLEOTIDES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEOTIDES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NUCLEOTIDES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. CANADA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CANADA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 53. CANADA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. CANADA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. CANADA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 56. CANADA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. MEXICO NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 58. MEXICO NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MEXICO NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 60. MEXICO NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. MEXICO NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. MEXICO NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 92. UNITED KINGDOM NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 96. GERMANY NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. FRANCE NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. FRANCE NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. FRANCE NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 103. FRANCE NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. FRANCE NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. FRANCE NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 106. FRANCE NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 108. RUSSIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. RUSSIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 110. RUSSIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. RUSSIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 112. RUSSIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 113. RUSSIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. ITALY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. ITALY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. ITALY NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 117. ITALY NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. ITALY NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ITALY NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 120. ITALY NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. SPAIN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. SPAIN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SPAIN NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 124. SPAIN NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. SPAIN NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. SPAIN NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 127. SPAIN NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 131. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 134. UNITED ARAB EMIRATES NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 138. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 141. SAUDI ARABIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 145. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 148. SOUTH AFRICA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. DENMARK NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. DENMARK NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. DENMARK NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 152. DENMARK NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. DENMARK NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. DENMARK NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 155. DENMARK NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 159. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. QATAR NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. QATAR NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. QATAR NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 166. QATAR NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. QATAR NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. QATAR NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 169. QATAR NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. FINLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FINLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. FINLAND NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 173. FINLAND NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. FINLAND NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 175. FINLAND NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 176. FINLAND NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 180. SWEDEN NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. SWEDEN NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. SWEDEN NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 183. SWEDEN NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. NIGERIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. NIGERIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. NIGERIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. EGYPT NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. EGYPT NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. EGYPT NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 194. EGYPT NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. EGYPT NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 197. EGYPT NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. TURKEY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. TURKEY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. TURKEY NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 201. TURKEY NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. TURKEY NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. TURKEY NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 204. TURKEY NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. ISRAEL NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. ISRAEL NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. ISRAEL NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 208. ISRAEL NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. ISRAEL NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. ISRAEL NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 211. ISRAEL NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 212. NORWAY NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NORWAY NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NORWAY NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 215. NORWAY NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. NORWAY NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. NORWAY NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 218. NORWAY NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 219. POLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. POLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. POLAND NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 222. POLAND NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. POLAND NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. POLAND NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 225. POLAND NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 228. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 229. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 231. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC NUCLEOTIDES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 241. CHINA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. CHINA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. CHINA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 244. CHINA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. CHINA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. CHINA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 247. CHINA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. INDIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. INDIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. INDIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 251. INDIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 253. INDIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 254. INDIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. JAPAN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. JAPAN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. JAPAN NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 258. JAPAN NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. JAPAN NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. JAPAN NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 261. JAPAN NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 265. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 282. INDONESIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. THAILAND NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 284. THAILAND NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. THAILAND NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 286. THAILAND NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 287. THAILAND NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. THAILAND NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 289. THAILAND NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 293. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 296. PHILIPPINES NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. SINGAPORE NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. SINGAPORE NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SINGAPORE NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 307. SINGAPORE NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SINGAPORE NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 309. SINGAPORE NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 310. SINGAPORE NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. VIETNAM NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. VIETNAM NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. VIETNAM NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 314. VIETNAM NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 315. VIETNAM NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. VIETNAM NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 317. VIETNAM NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN NUCLEOTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN NUCLEOTIDES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN NUCLEOTIDES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN NUCLEOTIDES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN NUCLEOTIDES MARKET SIZE, BY SYNTHESIS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN NUCLEOTIDES MARKET SIZE, BY PURITY GRADE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN NUCLEOTIDES MARKET SIZE, BY MARKET CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. NUCLEOTIDES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 326. NUCLEOTIDES MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Nucleotides market report include:
  • Evonik Industries AG
  • Ajinomoto Co., Inc.
  • DuPont de Nemours, Inc.
  • Kyowa Hakko Bio Co., Ltd.
  • Nitto Denko Corporation
  • Yamasa Corporation
  • Koninklijke DSM N.V.
  • Fujifilm Holdings Corporation
  • Amicogen Co., Ltd.
  • Global Bio-Chem Technology Group Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 708.29 Million
Forecasted Market Value ( USD ) by 2030 $ 1060 Million
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Nucleotide Market Size, Share & Trends Analysis Report by Product (Deoxy Nucleotides), Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), Application, and Region with Growth Forecasts, 2025-2030 - Product Image

Nucleotide Market Size, Share & Trends Analysis Report by Product (Deoxy Nucleotides), Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), Application, and Region with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Food Nucleotide Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Food Nucleotide Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Nucleotides Market Report by Type, Technology, Form, Application, and Region 2025-2033 - Product Image

Nucleotides Market Report by Type, Technology, Form, Application, and Region 2025-2033

  • Report
  • 136 Pages
  • Global
From
Food Nucleotides - Global Strategic Business Report - Product Image

Food Nucleotides - Global Strategic Business Report

  • Report
  • 487 Pages
  • Global
From
Single Nucleotide Polymorphism Genotyping Market 2025-2033 - Product Image

Single Nucleotide Polymorphism Genotyping Market 2025-2033

  • Report
  • 139 Pages
  • Global
From

About the Nucleotide Market

In biotechnology, the nucleotide market encompasses the production and sale of nucleotides, which are the basic building blocks of nucleic acids, namely DNA and RNA. This market serves a diverse array of applications including research, pharmaceuticals, diagnostics, and agricultural biotechnology. The synthesis of custom nucleotides enables advancements in genetic engineering, gene sequencing, and personalized medicine. Companies in this sector often provide both individual nucleotides for research and therapeutic purposes as well as oligonucleotides, which are short sequences of nucleotides synthesized to match specific DNA or RNA sequences for use in experiments or as drugs. The demand in this market is driven by the expanding understanding of genetic material and the increasing applicability of nucleic acid-based technologies. Environmental concerns and regulations also influence the production and sale of nucleotides. Key players in the nucleotide market include Thermo Fisher Scientific, a prominent provider of scientific instrumentation and reagents; Sigma-Aldrich (now part of Merck KGaA), known for chemicals and nucleotides for research purposes; Illumina, which specializes in sequencing and array-based technologies; and Integrated DNA Technologies, providing custom nucleic acids for various applications. Other notable companies include Agilent Technologies, which provides analytical instruments and services to the life sciences industry; and Eurofins Genomics, a leader in genomic services. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.